Brief: Autolus Therapeutics plc posts Q2 net income USD -45.552 million
03/08/2023 13:53
Aug 3 (Reuters) - Autolus Therapeutics plc Q2 pretax profit USD -49.022 million. * Q2 operating expenses USD -47.887 million * Q2 net income USD -45.552 million
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants